Growing Investment in Neurodegenerative Disease Research
The Parkinson’s disease drug market is entering a phase of steady transformation as pharmaceutical innovation, demographic shifts, and expanding diagnosis rates reshape the treatment landscape. Parkinson’s disease (PD) is a progressive neurodegenerative disorder that primarily affects movement, creating a long-term need for pharmacological therapy to manage symptoms and improve...
0 Commentarii 0 Distribuiri 81 Views 0 previzualizare
Sponsor